Published in J Pharm Biomed Anal on January 01, 1990
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
The Arabidopsis Information Resource (TAIR): a comprehensive database and web-based information retrieval, analysis, and visualization system for a model plant. Nucleic Acids Res (2001) 11.93
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 8.54
The Genome Sequence DataBase: towards an integrated functional genomics resource. Nucleic Acids Res (1999) 6.20
SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol (1997) 5.72
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A (2001) 4.13
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
A dual thrombin receptor system for platelet activation. Nature (1998) 3.96
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77
Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet (1998) 3.41
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
Surgical correction of refractive errors. J R Soc Med (2000) 3.25
Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature (2001) 3.15
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A (2000) 3.01
Crystal structure of delta9 stearoyl-acyl carrier protein desaturase from castor seed and its relationship to other di-iron proteins. EMBO J (1996) 2.84
Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol (2000) 2.81
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Genetic relationship of populations in China. Proc Natl Acad Sci U S A (1998) 2.65
Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol (2000) 2.61
A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (2001) 2.55
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
Analysis of the pressor dose response. Clin Pharmacol Ther (1982) 2.44
Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther (1981) 2.36
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene (2009) 2.33
Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.33
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
Microsurgical replantation of the avulsed scalp: report of 20 cases. Plast Reconstr Surg (1996) 2.17
Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology (1998) 2.17
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol (1982) 2.06
Signal, noise power spectrum, and detective quantum efficiency of indirect-detection flat-panel imagers for diagnostic radiology. Med Phys (1998) 2.06
Empirical and theoretical investigation of the noise performance of indirect detection, active matrix flat-panel imagers (AMFPIs) for diagnostic radiology. Med Phys (1997) 2.04
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet (1983) 2.03
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Topographic detection of photorefractive keratectomy. Ophthalmology (1998) 1.97
Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone (1999) 1.95
The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol Cell (1999) 1.92
Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. Br J Gen Pract (1994) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br J Clin Pharmacol (1983) 1.89
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A (2001) 1.84
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
Laminar comparison of somatosensory cortical plasticity. Science (1994) 1.76
Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. J Biol Chem (1994) 1.72
The genetics of keratoconus. Clin Experiment Ophthalmol (2001) 1.71
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem (1998) 1.68
Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J Biol Chem (2000) 1.66
Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet (2001) 1.65
Microstructural assessment of rare corneal dystrophies using real-time in vivo confocal microscopy. Clin Experiment Ophthalmol (2001) 1.65
Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development. Adverse Drug React Toxicol Rev (1999) 1.64
Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. J Biol Chem (1996) 1.63
Latent species C adenoviruses in human tonsil tissues. J Virol (2008) 1.63
Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol (1997) 1.62
Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc Natl Acad Sci U S A (1997) 1.61
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60
Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem (2000) 1.60
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem (1998) 1.59
A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci U S A (2001) 1.58
Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett (1997) 1.57
Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc Natl Acad Sci U S A (1994) 1.57
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) (1983) 1.56
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis. Antimicrob Agents Chemother (1995) 1.53
African origin of modern humans in East Asia: a tale of 12,000 Y chromosomes. Science (2001) 1.51
Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci (Lond) (1985) 1.49
Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int (2007) 1.48
Transdermal photopolymerized adhesive for seroma prevention. Plast Reconstr Surg (1999) 1.47
Verapamil pharmacokinetics and apparent hepatic and renal blood flow. Br J Clin Pharmacol (1985) 1.46
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis (1996) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun (1998) 1.43
Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.43
Laparoscopic versus open pyeloplasty: assessment of objective and subjective outcome. J Urol (1999) 1.43
Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. Crit Care Med (1999) 1.43
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem (1994) 1.40
Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim Biophys Acta (1999) 1.39
Cigarette advertising and onset of smoking in children: questionnaire survey. BMJ (1996) 1.38
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol (2012) 1.38
Cardiogenic shock with takotsubo-like cardiomyopathy in functional retroperitoneal paraganglioma. Herz (2014) 1.38
Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem (2000) 1.37
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut (1984) 1.36
The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev (2001) 1.36
Human placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization. J Biol Chem (1999) 1.35
Incidence of anomalous origin of coronary artery in 1879 Chinese adults on dual-source CT angiography. Neth Heart J (2010) 1.35
Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol (1997) 1.35
Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function. Biochem Biophys Res Commun (1999) 1.35
stumps, a Drosophila gene required for fibroblast growth factor (FGF)-directed migrations of tracheal and mesodermal cells. Genetics (1999) 1.34
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells. Oncogene (2009) 1.34
Corneal tattooing revisited: excimer laser in the treatment of unsightly leucomata. Aust N Z J Ophthalmol (1995) 1.33